or Try an Advanced Search...

    Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 36.45 -0.27% -0.10
    SWTX closed down 0.27 percent on Friday, November 15, 2024, on 3.45 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical SWTX trend table...
    Date Alert Name Type % Chg
    Volume Surge Other 0.00%
    Calm After Storm Range Contraction 0.00%
    Doji - Bearish? Reversal 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Stochastic Reached Overbought Strength -0.27%
    Upper Bollinger Band Walk Strength -0.27%
    Above Upper BB Strength -0.27%
    Older End-of-Day Signals for SWTX ...

       Recent Intraday Alerts

    Alert Time
    Up 2% 2 days ago
    Rose Above Previous Day's High 3 days ago
    Up 1% 3 days ago
    60 Minute Opening Range Breakout 3 days ago
    2x Volume Pace 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SWTX Chart by TradingView
    Basic chart:

    Profile

    Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development

    Is SWTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Analyst Estimates: Here's What Brokers Think Of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Report
    Nov 13 SpringWorks Therapeutics Inc (SWTX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
    Nov 12 SpringWorks Therapeutics, Inc. (SWTX) Q3 2024 Earnings Call Transcript
    Nov 12 SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference
    Nov 12 SpringWorks Therapeutics’ mirdametinib shows efficacy in neurofibromatosis study
    Nov 12 SpringWorks Therapeutics gives mixed Q3 results
    Nov 12 SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
    Nov 12 Earnings Scheduled For November 12, 2024
    Nov 11 SpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
    Nov 11 SpringWorks Therapeutics Announces Publication of the Pivotal Phase 2b ReNeu Trial Evaluating Mirdametinib in Adults and Children with NF1-PN in the Journal of Clinical Oncology
    See more SWTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.92
    52 Week Low 20.1919
    Average Volume 1,106,307
    200-Day Moving Average 40.17
    50-Day Moving Average 32.70
    20-Day Moving Average 31.78
    10-Day Moving Average 33.69
    Average True Range 1.86
    RSI (14) 71.35
    ADX 17.93
    +DI 27.79
    -DI 19.34
    Chandelier Exit (Long, 3 ATRs) 31.95
    Chandelier Exit (Short, 3 ATRs) 33.80
    Upper Bollinger Bands 36.42
    Lower Bollinger Band 27.13
    Percent B (%b) 1.0
    BandWidth 29.21
    MACD Line 0.93
    MACD Signal Line 0.19
    MACD Histogram 0.7402
    Fundamentals Value
    Market Cap 2.63 Billion
    Num Shares 72.1 Million
    EPS -4.87
    Price-to-Earnings (P/E) Ratio -7.48
    Price-to-Sales 74.50
    Price-to-Book 8.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 40.01
    Resistance 3 (R3) 39.97 38.76 39.41
    Resistance 2 (R2) 38.76 37.85 38.77 39.21
    Resistance 1 (R1) 37.60 37.29 37.00 37.64 39.02
    Pivot Point 36.39 36.39 36.08 36.40 36.39
    Support 1 (S1) 35.23 35.48 34.63 35.27 33.88
    Support 2 (S2) 34.02 34.92 34.03 33.69
    Support 3 (S3) 32.86 34.02 33.49
    Support 4 (S4) 32.90